Microbiome stool tests can help practitioners identify the presence and abundance of various bacterial species, fungi, viruses and other microorganisms in their patients. This information can help tailor interventions and treatments specific to an individual’s gut microbiome. Many of these stool tests check for the presence and abundance of the keystone strain, Akkermansia muciniphila.
Akkermansia is on the forefront of microbiome research, touted for its ability to strengthen gut barrier function and produce health-promoting short-chain fatty acids.
Join us on June 28th at 2pm ET as Colleen Cutcliffe, Co-founder and CEO of Pendulum, explains the emerging science linking Akkermansia to healthy weight, intestinal integrity, and other health outcomes that may improve the way we age, and how to utilize Akkermansia levels on stool tests to inform clinical practice.
During this informative webinar, Colleen will discuss:
.jpeg)
.png)
.png)
